Continuous glucose monitoring (CGM) in patients with diabetes mainly treated with ICT: Clinical application and evidence

被引：0

作者：

Thomas, A. ^{[1
]}

Schlueter, S. ^{[1
,2
]}

Naudorf, M. ^{[1
,3
]}

Deiss, D. ^{[1
,4
]}

Freckmann, G. ^{[1
,5
]}

Danne, E. ^{[1
,6
]}

机构：

[1] Deutsch Diabet Gesell, Arbeitsgemeinschaft Diabet & Technol AGDT, Berlin, Germany

[2] Diabet Praxis Nordheim, Nordheim, Germany

[3] Diabet Zentrum Lindlar, Lindlar, Germany

[4] MEDICOVER Berlin Mitte, Berlin, Germany

[5] Univ Ulm, Inst Diabet Technol Forsch & Entwicklungsgesell, Ulm, Germany

[6] Diabet Zentrum Kinder & Jugendl Kinder & Jugendkr, Hannover, Germany

来源：

DIABETES STOFFWECHSEL UND HERZ | 2022年 / 31卷 / 02期

关键词：

Continuous glucose monitoring (CGM); real-time CGM; iscCGM; evidence; indications; hypoglycaemia; hyperglycaemia; consensus; DAILY INSULIN INJECTIONS; GLYCEMIC CONTROL; REAL-TIME; SENSING TECHNOLOGY; SEVERE HYPOGLYCEMIA; OPEN-LABEL; MULTICENTER; ACCURACY; ADULTS; SENSOR;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Continuous glucose monitoring (CGM) has become a tool of choice in state-ofthe-art diabetes management with the added benefit of replacing self-monitoring of blood glucose (SMBG) in some cases, which many patients find stressful. CGM also plays an essential role in automated insulin delivery (AID) systems and has increasingly become state of the art in type 1 diabetes treatment and care. Even so, CGM is costly at between _4 and _10 per day currently, requiring responsible use of CGM in terms of patient selection and indication. Germany's Diabetes & Technology Working Group (AGDT) first assessed CGM in 2012 regarding the technology and literature available at the time, and defined indications for the practical use of CGM in Germany in a consensus statement. The resulting comments on various indications and developments will be covered in the following. This contribution will describe the current status of CGM as based on statements given by the AGDT up to now. A recently published analysis [Lin 2021] has confirmed the analysis performed by the AGDT.

引用

页码：92 / 109

页数：18

共 76 条

[1] Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes [J].

Alva, Shridhara ;

Bailey, Timothy ;

Brazg, Ronald ;

Budiman, Erwin S. ;

Castorino, Kristin ;

Christiansen, Mark P. ;

Forlenza, Gregory ;

Kipnes, Mark ;

Liljenquist, David R. ;

Liu, Hanqing .

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2022, 16 (01) :70-77

[2]

American Diabetes Association, 2021, Diabetes Care, V44, pS85, DOI [10.2337/dc21-S007, DOI 10.2337/DC21-S007]

[3]

[Anonymous], 1995, US FOOD DRUG ADM

[4]

[Anonymous], 2021, KELL CLOS REP

[5]

[Anonymous], 2014, DIABETES CARE, V37, P2114

[6] Q-Score: development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies [J].

Augstein, Petra ;

Heinke, Peter ;

Vogt, Lutz ;

Vogt, Roberto ;

Rackow, Christine ;

Kohnert, Klaus-Dieter ;

Salzsieder, Eckhard .

BMC ENDOCRINE DISORDERS, 2015, 15

[7] Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range [J].

Battelino, Tadej ;

Danne, Thomas ;

Bergenstal, Richard M. ;

Amiel, Stephanie A. ;

Beck, Roy ;

Biester, Torben ;

Bosi, Emanuele ;

Buckingham, Bruce A. ;

Cefalu, William T. ;

Close, Kelly L. ;

Cobelli, Claudio ;

Dassau, Eyal ;

DeVries, J. Hans ;

Donaghue, Kim C. ;

Dovc, Klemen ;

Doyle, Francis J. ;

Garg, Satish ;

Grunberger, George ;

Heller, Simon ;

Heinemann, Lutz ;

Hirsch, Irl B. ;

Hovorka, Roman ;

Jia, Weiping ;

Kordonouri, Olga ;

Kovatchev, Boris ;

Kowalski, Aaron ;

Laffel, Lori ;

Levine, Brian ;

Mayorov, Alexander ;

Mathieu, Chantal ;

Murphy, Helen R. ;

Nimri, Revital ;

Norgaard, Kirsten ;

Parkin, Christopher G. ;

Renard, Eric ;

Rodbard, David ;

Saboo, Banshi ;

Schatz, Desmond ;

Stoner, Keaton ;

Urakami, Tatsuiko ;

Weinzimer, Stuart A. ;

Phillip, Moshe .

DIABETES CARE, 2019, 42 (08) :1593-1603

[8] Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials [J].

Beck, Roy W. ;

Bergenstal, Richard M. ;

Riddlesworth, Tonya D. ;

Kollman, Craig ;

Li, Zhaomian ;

Brown, Adam S. ;

Close, Kelly L. .

DIABETES CARE, 2019, 42 (03) :400-405

[9] Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections A Randomized Trial [J].

Beck, Roy W. ;

Riddlesworth, Tonya D. ;

Ruedy, Katrina ;

Ahmann, Andrew ;

Haller, Stacie ;

Kruger, Davida ;

McGill, Janet B. ;

Polonsky, William ;

Price, David ;

Aronoff, Stephen ;

Aronson, Ronnie ;

Toschi, Elena ;

Kollman, Craig ;

Bergenstal, Richard .

ANNALS OF INTERNAL MEDICINE, 2017, 167 (06) :365-+

[10] Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections The DIAMOND Randomized Clinical Trial [J].

Beck, Roy W. ;

Riddlesworth, Tonya ;

Ruedy, Katrina ;

Ahmann, Andrew ;

Bergenstal, Richard ;

Haller, Stacie ;

Kollman, Craig ;

Kruger, Davida ;

McGill, Janet B. ;

Polonsky, William ;

Toschi, Elena ;

Wolpert, Howard ;

Price, David .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (04) :371-378

← 1 2 3 4 5 6 7 8 →